BJA FY 14 Harold Rogers Prescription Drug Monitoring Program

Funding Opportunity Number: BJA-2014-3767 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Law, Justice and Legal ServicesCFDA Number: 16.754Eligible Applicants State governmentsNative American tribal governments (Federally recognized)Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: USDOJ-OJP-BJAClosing Date: May 06, 2014Award Ceiling: $400,000Expected Number of Awards: Creation Date: Mar 11, 2014Funding Opportunity Description: The primary purpose of the Harold Rogers Prescription Drug Monitoring Program (PDMP) is to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized state agency. The program was created by the FY 2002 U.S. Department of Justice Appropriations Act (Public Law 107-77) and has received funding under each subsequent yearÂ’s Appropriations Act.
Source: Grants.gov - Category: Research Tags: Law, Justice and Legal Services Source Type: funding

Related Links:

Publication date: Available online 21 November 2019Source: Journal of Cancer PolicyAuthor(s): Brandon Maser, Lisa M. Force, Paola Friedrich, Federico Antillon, Ramandeep S. Arora, Cristian A. Herrera, Carlos Rodriguez-Galindo, Rifat Atun, Avram DenburgAbstractTo help understand how health systems and sociopolitical contexts intersect with and impact the performance of childhood cancer care in low- and middle-income countries (LMICs), we have developed a systems-level framework for analyzing the performance of LMIC childhood cancer programs within their health system contexts: The Paediatric Oncology System Integration Tool...
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Source Type: research
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Source Type: research
Date: Thursday, 12 12, 2019; Speaker: Julie Blendy , Ph.D. Professor of Pharmacology, Perelman School of Medicine, University of Pennsylvania; Building: Building 40; 1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Thursday, 12 19, 2019; Speaker: Cristine Delnevo, Ph.D., M.P.H., F.A.A.H.B., Director, Center for Tobacco Studies, Society and Policy Rutgers School of Public Health; Nir Eyal, D.Phil, Director, Center for Population-Level Bioethics (CPLB), Society and Policy Rutgers School of Public Health; https://epi.grants.cancer.gov/events/enrich-forum/
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 01 27, 2020; Speaker: Lisa Ingraham, Ph.D., University of California, San Francisco; Porter Neuroscience Bldg, 35a; G620-640; Videocast Event
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Friday, 11 22, 2019; Speaker: various; Building 38; Conference room B, second floor
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Friday, 11 22, 2019; Speaker: Nicola Santoro, MD, PhD, Assistant Professor of Pediatrics (Endocrinology), Yale School of Medicine; Building 10 CRC; FAES 1&2
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 11 25, 2019; Speaker: Eugene M. Oltz , Chair of the Department of Microbial Infection and Immunity , College of Medicine – The Ohio State University; 37; 6041
Source: NIH Calendar of Events - Category: American Health Source Type: events
More News: Chemistry | Databases & Libraries | Funding | Grants | Health | International Medicine & Public Health | Legislation | Research